Inflammatory reconstitution immune syndrome associated to antiretroviral therapy and meningeal cryptococcosis Síndrome de restauración inmune asociado a tratamiento antirretroviral y criptococosis meníngea. Caso clínico
Author
dc.contributor.author
David Sáez, M.
Author
dc.contributor.author
Laura Bahamondes, M.
Author
dc.contributor.author
Gislaine Lam, E.
Author
dc.contributor.author
Luz Arellano, R.
Author
dc.contributor.author
Patricia Lillo, Z.
Admission date
dc.date.accessioned
2019-03-11T12:53:08Z
Available date
dc.date.available
2019-03-11T12:53:08Z
Publication date
dc.date.issued
2006
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 134, Issue 10, 2018, Pages 1310-1314
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164233
Abstract
dc.description.abstract
The objective of high activity antiretroviral therapy (HAART) in patients with AIDS, is to obtain immune restoration. This means a reduction of the viral load and restitution of the CD4 cell count. A decreased rate of HIV replication improves both the number and function of CD4 cells. Nevertheless, this treatment sometimes results in the reappearance of previous symptoms from treated conditions due to opportunistic infections (ie: tuberculosis, criptococcosis, hepatitis, Pneumocystis jirovesi, toxoplasmosis, etc) or non infectious condition such as sarcoidosis, Graves disease or Kaposi sarcoma. This is known as Inflammatory Reconstitution Immune Syndrome (IRIS). We report a 37 year-old woman in stage C3-AIDS with a previous criptococcal meningitis. She was treated, achieving a marked improvement with treatment and subsequent suppressive therapy with fluconazole 200 mg/day. IRIS appeared after 8 months of ongoing antiretroviral therapy with immune restoration with the development of ase
Inflammatory reconstitution immune syndrome associated to antiretroviral therapy and meningeal cryptococcosis Síndrome de restauración inmune asociado a tratamiento antirretroviral y criptococosis meníngea. Caso clínico